Thus, recent advances gained from transgenic models suggest that striatal GDNF plays a key role in the maintenance of the nigrostriatal DA pathway and constitutes a potential target to fight against the progressive motor decline associated to PD. The gene discussed is GDNF; the disease is Parkinson disease.